Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Re-epithelializaiton by epithelial inoculation with recipient phenotype in heterotopically transplanted rat allografts.

Zheng H, Hu X, Li C, Xie H, Gao W, Chen C.

Chin Med J (Engl). 2014;127(10):1913-8.

PMID:
24824255
2.

Epithelial re-growth is associated with inhibition of obliterative airway disease in orthotopic tracheal allografts in non-immunosuppressed rats.

Ikonen TS, Brazelton TR, Berry GJ, Shorthouse RS, Morris RE.

Transplantation. 2000 Sep 27;70(6):857-63.

PMID:
11014638
3.

Seeding of recipient-originated epithelial cells attenuates epithelial to mesenchymal transition in rat tracheal allotransplantation.

Huang X, Yan X, Zhang Z, Li X.

Otolaryngol Head Neck Surg. 2015 Jun;152(6):1068-74. doi: 10.1177/0194599815577102. Epub 2015 Mar 27.

PMID:
25820583
4.

The kinetics and pattern of tracheal allograft re-epithelialization.

Genden EM, Iskander A, Bromberg JS, Mayer L.

Am J Respir Cell Mol Biol. 2003 Jun;28(6):673-81.

PMID:
12760965
5.

[Establishment of obliterative bronchiolitis in allo-trachea transplant model of rat and detection of its pathogenesis preliminarily].

Qi Z, Yang DY, Wang R, Wang SZ, Ping YM.

Zhonghua Wai Ke Za Zhi. 2007 Feb 15;45(4):262-6. Chinese.

PMID:
17502025
6.

Orthotopic tracheal allografts undergo reepithelialization with recipient-derived epithelium.

Genden EM, Iskander AJ, Bromberg JS, Mayer L.

Arch Otolaryngol Head Neck Surg. 2003 Jan;129(1):118-23.

PMID:
12525206
7.

Suppression of the obliteration process by ventilation in a mouse orthotopic tracheal transplantation model.

Chen C, Zhang YZ, Zheng H, Xu BB, Gao W.

Transplantation. 2009 Jun 27;87(12):1762-8. doi: 10.1097/TP.0b013e3181a6618a.

PMID:
19543051
8.

Tissue inhibitor of metalloproteinase-1 deficiency abrogates obliterative airway disease after heterotopic tracheal transplantation.

Chen P, Farivar AS, Mulligan MS, Madtes DK.

Am J Respir Cell Mol Biol. 2006 Apr;34(4):464-72. Epub 2005 Dec 30.

9.

Obliterative airway disease after heterotopic tracheal xenotransplantation: pathogenesis and prevention using new immunosuppressive agents.

Reichenspurner H, Soni V, Nitschke M, Berry GJ, Brazelton TR, Shorthouse R, Huang X, Reitz BA, Morris RE.

Transplantation. 1997 Aug 15;64(3):373-83.

PMID:
9275099
10.

Immunosuppressive therapies for the prevention and treatment of obliterative airway disease in heterotopic rat trachea allografts.

Adams BF, Berry GJ, Huang X, Shorthouse R, Brazelton T, Morris RE.

Transplantation. 2000 Jun 15;69(11):2260-6.

PMID:
10868623
11.

Inhibiting CXCL12 blocks fibrocyte migration and differentiation and attenuates bronchiolitis obliterans in a murine heterotopic tracheal transplant model.

Harris DA, Zhao Y, LaPar DJ, Emaminia A, Steidle JF, Stoler M, Linden J, Kron IL, Lau CL.

J Thorac Cardiovasc Surg. 2013 Mar;145(3):854-61. doi: 10.1016/j.jtcvs.2012.03.079. Epub 2012 May 22.

12.

Increased matrix metalloproteinase-2 and membrane type 1 matrix metalloproteinase activity and expression in heterotopically transplanted murine tracheas.

Inaki N, Tsunezuka Y, Kawakami K, Sato H, Takino T, Oda M, Watanabe G.

J Heart Lung Transplant. 2004 Feb;23(2):218-27.

PMID:
14761770
13.
14.

Airway goblet cells and respiratory epithelial injury in an animal model of obliterative airways disease (OAD).

Dosanjh A, Wan B, Ikonen T, Boeke K, Morris RE.

Am J Transplant. 2001 Nov;1(4):321-4.

15.

The effect of decellularization of tracheal allografts on leukocyte infiltration and of recellularization on regulatory T cell recruitment.

Haykal S, Zhou Y, Marcus P, Salna M, Machuca T, Hofer SO, Waddell TK.

Biomaterials. 2013 Jul;34(23):5821-32. doi: 10.1016/j.biomaterials.2013.04.044. Epub 2013 May 8.

PMID:
23663928
16.

Role of airway epithelial injury in murine orthotopic tracheal allograft rejection.

Kuo E, Bharat A, Shih J, Street T, Norris J, Liu W, Parks W, Walter M, Patterson GA, Mohanakumar T.

Ann Thorac Surg. 2006 Oct;82(4):1226-33.

PMID:
16996912
17.

Techniques for experimental heterotopic and orthotopic tracheal transplantations - When to use which model?

Deuse T, Schrepfer S, Reichenspurner H, Hoyt G, Fischbein MP, Robbins RC, Pelletier MP.

Transpl Immunol. 2007 Jun;17(4):255-61. Epub 2007 Feb 6.

PMID:
17493528
18.

Heterotopic tracheal transplantation animal model of bronchiolitis obliterans: a reproducible model.

Gómez-de-Antonio D, Campo-Cañaveral de la Cruz JL, Gonzalez-Lois C, Santos M, Millán I, Varela de Ugarte A.

Ann Transplant. 2013 Dec 6;18:661-70. doi: 10.12659/AOT.884031.

19.

Enhancement of obliterative airway disease in rat tracheal allografts infected with recombinant rat cytomegalovirus.

Reichenspurner H, Soni V, Nitschke M, Berry GJ, Brazelton T, Shorthouse R, Huang X, Boname J, Girgis R, Raitz BA, Mocarski E, Sandford G, Morris RE.

J Heart Lung Transplant. 1998 May;17(5):439-51.

PMID:
9628562
20.

Blocking the CD28-B7 T-cell costimulatory pathway abrogates the development of obliterative bronchiolitis in a murine heterotopic airway model.

Yamada A, Konishi K, Cruz GL, Takehara M, Morikawa M, Nakagawa I, Murakami M, Abe T, Todo S, Uede T.

Transplantation. 2000 Mar 15;69(5):743-9.

PMID:
10755520

Supplemental Content

Support Center